Goossens, S., Peirs, S., Van Loocke, W., Wang, J., Takawy, M., Matthijssens, F., . . . Haigh, J. J. (2017). Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia. Blood.
Chicago Style aipamenaGoossens, Steven, et al. "Oncogenic ZEB2 Activation Drives Sensitivity Toward KDM1A Inhibition in T-cell Acute Lymphoblastic Leukemia." Blood 2017.
MLA aipamenaGoossens, Steven, et al. "Oncogenic ZEB2 Activation Drives Sensitivity Toward KDM1A Inhibition in T-cell Acute Lymphoblastic Leukemia." Blood 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.